Gnosis ( Pharmaceuticals and Biotechnology) Overview
- Year Founded
-
1989
- Status
-
Acquired/Merged
- Employees
-
400
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Gnosis ( Pharmaceuticals and Biotechnology) General Information
Description
Provider of biotechnology services based in Italy. The company specializes in the manufacturing and sales of fermentation raw materials and natural finished products used in the pharmaceutical, nutraceutical, cosmetic, veterinary, and agricultural industries.
Contact Information
Website
www.gnosis-bio.comCorporate Office
- Piazza del Carmine, 4
- 20121 Milan
- Italy
Corporate Office
- Piazza del Carmine, 4
- 20121 Milan
- Italy
Gnosis ( Pharmaceuticals and Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Gnosis ( Pharmaceuticals and Biotechnology) Comparisons
Industry
Financing
Details
Gnosis ( Pharmaceuticals and Biotechnology) Competitors (3)
One of Gnosis ( Pharmaceuticals and Biotechnology)’s 3 competitors is A ChemTek, a Accelerator/Incubator Backed company based in Woburn, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| A ChemTek | Accelerator/Incubator Backed | Woburn, MA | ||||
| Biosynth | Private Equity-Backed | Berkshire, United Kingdom | ||||
| Spectrum Laboratory Products | Formerly PE-Backed | New Brunswick, NJ |
Gnosis ( Pharmaceuticals and Biotechnology) Patents
Gnosis ( Pharmaceuticals and Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2019239340-A1 | Reduced glutathione in a highly soluble, amorphous solid form, and process for the preparation thereof | Inactive | 14-Jun-2018 | ||
| AU-2018298404-A1 | Salt of (ss)-adenosyl methionine with inositol hexaphosphate, and process for the preparation thereof | Inactive | 04-Jul-2017 | ||
| EP-3648770-A1 | Salt of (ss)-adenosyl methionine with inositol hexaphosphate, and process for the preparation thereof | Inactive | 04-Jul-2017 | ||
| US-20190010182-A1 | Salt of (ss)-adenosyl methionine with inositol hexaphosphate, and process for the preparation thereof | Inactive | 04-Jul-2017 | ||
| US-20200165287-A1 | Salt of (ss)-adenosyl methionine with inositol hexaphosphate, and process for the preparation thereof | Inactive | 04-Jul-2017 | C07H19/16 |
Gnosis ( Pharmaceuticals and Biotechnology) Signals
Gnosis ( Pharmaceuticals and Biotechnology) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Gnosis ( Pharmaceuticals and Biotechnology) Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Omniabios | Bagnolo Mella, Italy | 1963 |
Gnosis ( Pharmaceuticals and Biotechnology) FAQs
-
When was Gnosis ( Pharmaceuticals and Biotechnology) founded?
Gnosis ( Pharmaceuticals and Biotechnology) was founded in 1989.
-
Where is Gnosis ( Pharmaceuticals and Biotechnology) headquartered?
Gnosis ( Pharmaceuticals and Biotechnology) is headquartered in Milan, Italy.
-
What is the size of Gnosis ( Pharmaceuticals and Biotechnology)?
Gnosis ( Pharmaceuticals and Biotechnology) has 400 total employees.
-
What industry is Gnosis ( Pharmaceuticals and Biotechnology) in?
Gnosis ( Pharmaceuticals and Biotechnology)’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Gnosis ( Pharmaceuticals and Biotechnology) a private or public company?
Gnosis ( Pharmaceuticals and Biotechnology) is a Private company.
-
What is Gnosis ( Pharmaceuticals and Biotechnology)’s current revenue?
The current revenue for Gnosis ( Pharmaceuticals and Biotechnology) is .
-
Who are Gnosis ( Pharmaceuticals and Biotechnology)’s investors?
S Solar has invested in Gnosis ( Pharmaceuticals and Biotechnology).
-
Who are Gnosis ( Pharmaceuticals and Biotechnology)’s competitors?
A ChemTek, Biosynth, and Spectrum Laboratory Products are competitors of Gnosis ( Pharmaceuticals and Biotechnology).
-
When was Gnosis ( Pharmaceuticals and Biotechnology) acquired?
Gnosis ( Pharmaceuticals and Biotechnology) was acquired on 01-Oct-2015.
-
Who acquired Gnosis ( Pharmaceuticals and Biotechnology)?
Gnosis ( Pharmaceuticals and Biotechnology) was acquired by Lesaffre.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process